Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-28 | New | $3,250,001 | $3,250,001 | Equity Only | 06b | SEC link |
| 2024-08-16 | New | $10,000,000 | $10,000,000 | Equity Only | 06b | SEC link |
| 2015-06-08 | New | $5,070,000 | $5,070,000 | Other | 06b | SEC link |
| 2014-06-24 | New | $8,500,000 | $8,500,000 | Equity Only | 06b | SEC link |
| 2011-06-14 | New | $8,580,000 | $8,580,000 | Equity Only | 06 | SEC link |
| 2010-07-26 | New | $139,744 | $139,744 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Khursheed Anwer | Executive |
| Nicholas Borys | Executive |
| Donald P. Braun | Director |
| Augustine Chow | Director |
| Jeffrey W. Church | Executive |
| James E. Dentzer | Director |
| Susan Eylward | Executive |
| Douglas Faller | Executive |
| Frederick J. Fritz | Director |
| David Gaiero | Executive |
| Robert W. Hooper | Director |
| Stacy R. Lindborg | Director, Executive |
| Max E. Link | Director |
| Alberto Martinez | Director |
| Gary W. Pace | Director |
| Christine Pellizzari | Director |
| Robert A Reed | Executive |
| Michael H. Tardugno | Director, Executive |
| Timothy J. Tumminello | Executive |
| Gregory Weaver | Director |